Isocarboxazid and Dopamine: Interaction Details

Brand names
Isocarboxazid
Marplan
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

What Happens When You Take Isocarboxazid With Dopamine

What can happen when they are taken together (rated Contraindicated)

An increased risk of (headache, hyperpyrexia, hypertension)

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Isocarboxazid should not be given together with DOPamine (a sympathomimetic), because the combination may provoke hypertension, headache, and related symptoms. Some patients appear to be especially susceptible to sympathomimetic effects while taking isocarboxazid, since the enzymes that normally metabolize these agents are inhibited.1

Sympathomimetics with indirect or mixed activity, DOPamine among them, can trigger release of the large stores of norEPINEPHrine that build up during MAO . The resulting excessive noradrenergic stimulation raises blood pressure. Agents that act more directly, such as norEPINEPHrine, EPINEPHrine, and isoproterenol, carry only a minimal risk of interaction.34

The Isocarboxazid and Dopamine Interaction, Explained

These two medicines should not be used together. Isocarboxazid (Marplan) is an antidepressant that blocks the enzyme that breaks down chemicals like norepinephrine in your body. Dopamine, usually given in a hospital for low blood pressure or shock, can make your body release that stored-up norepinephrine all at once. The result can be a sudden, dangerous rise in blood pressure, with a severe headache, high fever, and a pounding heartbeat.

This can happen quickly. If you take isocarboxazid, make sure every doctor, nurse, and pharmacist knows it, especially in an emergency or before a procedure. Your care team can choose safer options and manage this for you. Please don't change any medicine on your own.

. Isocarboxazid (irreversible nonselective ) increases neuronal norepinephrine stores. Dopamine has indirect/mixed sympathomimetic activity and can displace these stores, causing excessive noradrenergic stimulation.

  • Effect: (headache, hyperpyrexia, marked hypertension).
  • Onset: rapid. Evidence: probable.
  • Management: avoid . Direct-acting agents (norepinephrine, epinephrine, isoproterenol) carry minimal interaction liability, though dosing should be cautious and individualized. Some patients appear particularly vulnerable when MAO activity is inhibited. If exposure occurs, monitor blood pressure and temperature closely.

See the 8 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Isocarboxazid and Dopamine Interact

The likely mechanism

Increased norEPINEPHrine availability

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Isocarboxazid and Dopamine Interaction

The documented advice is to avoid using these two together, so your care team will usually look for a different option rather than adjust doses.

  • Tell every clinician, including emergency and hospital staff, that you take isocarboxazid.
  • Keep taking your isocarboxazid as prescribed unless your prescriber tells you otherwise.
  • If a sympathomimetic like dopamine may be needed, your team can weigh alternatives and monitor you more closely.
  • Seek urgent help for a sudden severe headache, fever, or very high blood pressure.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Isocarboxazid or Dopamine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

4 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Increased blood pressure responses to dopamine and norepinephrine produced by monoamine oxidase inhibitors in man

    MAO metabolizes DOPamine, so its effects are prolonged in patients who are taking . This interaction may lead to severe hypertension and/or cardiac . Patients receiving MAO inhibitors should be given no more than one-tenth of the usual DOPamine dose.5

  2. Report 2 · Study title

    Potentiation of amphetamine and pethidine by monoamine oxidase inhibitors

    The literature well documents severe headaches and hypertensive crises in association with this combination. Other possible reactions are nausea, vomiting, cardiac , chest pain, intracranial bleeding, circulatory failure, hyperpyrexia, and death.62

  3. Report 3 · Study title

    Psychotropic drugs (2)

    Sympathomimetic drugs that should be avoided during isocarboxazid therapy are amphetamines, ePHEDrine, metaraminol, phenylephrine, phenylpropanolamine, and mephentermine.78

  4. Report 4 · Study title

    Monoamine oxidase inhibitors

    The mechanism underlying this interaction is thought to be catecholamine release caused by the sympathomimetic drug. This frees a larger quantity of norEPINEPHrine, which is then available to bind to the receptor.2

    Sympathomimetics with indirect or mixed activity, such as DOPamine, can release large amounts of norEPINEPHrine that have built up during MAO , producing excessive noradrenergic stimulation and a rise in blood pressure. More direct acting agents such as norEPINEPHrine, EPINEPHrine, and isoproterenol carry minimal potential for interaction.34

Isocarboxazid and Dopamine: Common Questions

How serious is the Isocarboxazid and Dopamine interaction?

It is rated . These should generally not be used together.

How is the Isocarboxazid and Dopamine interaction managed?

The documented advice is to avoid using these two together, so your care team will usually look for a different option rather than adjust doses. Tell every clinician, including emergency and hospital staff, that you take isocarboxazid. Keep taking your isocarboxazid as prescribed unless your prescriber tells you otherwise. If a sympathomimetic like dopamine may be needed, your team can weigh alter… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Isocarboxazid and Dopamine Interaction

Ask in your own words about taking Isocarboxazid and Dopamine together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (8)

  1. Product Information: MARPLAN oral tablets, isocarboxazid oral tablets. Validus Pharmaceuticals LLC (per Dailymed), Parsippany, NJ, 2023. DailyMed
  2. Goldberg LI: Monoamine oxidase inhibitors. Adverse reactions and possible mechanisms. JAMA 1964; 190:456-462. DOI
  3. Smookler S & Bermudez AJ: Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant. Ann Emerg Med 1982; 11:482-484. PubMed
  4. Boakes AJ, Laurence DR, Teoh PC, et al: Interactions between sympathomimetic amines and antidepressant agents in man. Br Med J 1973; 1:311-315. PubMed
  5. Horwitz D, Goldberg LI, & Sjoerdsma A: Increased blood pressure responses to dopamine and norepinephrine produced by monoamine oxidase inhibitors in man. J Lab Clin Med 1960; 56:747.
  6. Brownlee G & Williams GW: Potentiation of amphetamine and pethidine by monoamine oxidase inhibitors. Lancet 1963; 1:669.
  7. Sjoqvist F: Psychotropic drugs (2). Interaction between monoamine oxidase (MAO) inhibitors and other substances. Proc R Soc Med 1965; 58:967-978. PubMed
  8. Elis J, Laurence DR, Mattie H, et al: Modification by monoamine oxidase inhibitors of the effect of some sympathomimetics on blood pressure. Br Med J 1967; 2:75-78. DOI
Was this write-up helpful?

Other Serious Interactions of Isocarboxazid and Dopamine

Also serious with Isocarboxazid

Also serious with Dopamine

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Isocarboxazid

With Dopamine

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together. This interaction.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs. This interaction.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.